| By Carolyn Y. Johnson When Angelina Jolie published an essay in the New York Times about her decision in 2013 to get a double mastectomy, the essay quickly went viral. Jolie's frank and candid admission that she had inherited a "faulty" BRCA1 gene that increased her risk of developing breast and ovarian cancer and struggled with what to … | | |  | | | | The latest economic and domestic policy from Wonkblog | | | | |  (Washington Post illustration; Oli Scarff/Getty; iStock) By Carolyn Y. Johnson When Angelina Jolie published an essay in the New York Times about her decision in 2013 to get a double mastectomy, the essay quickly went viral. Jolie's frank and candid admission that she had inherited a "faulty" BRCA1 gene that increased her risk of developing breast and ovarian cancer and struggled with what to do struck a chord with people. Jolie revealed that she had undergone a medical procedure rarely talked about openly, much less by A-list celebrities, and said she hoped her experience could help others. "Today it is possible to find out through a blood test whether you are highly susceptible to breast and ovarian cancer, and then take action," Jolie wrote. A new study published in the British Medical Journal found that thousands of additional women got tested for mutations in the breast cancer risk genes in the U.S. -- but probably not the right women. Read the rest on Wonkblog. Top policy tweets | | | | | | | | | | | ©2016 The Washington Post, 1301 K St NW, Washington DC 20071 | | | | | | | | |
No comments:
Post a Comment